This activity uses clinical cases to address the challenges of clinical inertia when caring for patients with type 2 diabetes mellitus. The discussion of treatment options includes consideration of the progressive nature of diabetes, current treatment guidelines, and interprofessional strategies to improve patient care.

Agenda

Welcome and Introductions

Current Guidelines: Choosing the Right Medication for Your Patient

Clinical Case Vignettes: Individualizing Therapy and Overcoming Clinical Inertia
and

Panel Discussion: Questions and Answers

Learning Objectives

  • Identify the current guidelines and the latest evidence for appropriate therapy in patients with type 2 diabetes mellitus and with or without comorbidities. 
  • Identify patient and provider barriers to overcoming clinical inertia. 
  • Devise interprofessional strategies to maximize patient engagement in developing a diabetes care plan and achieving individualized treatment goals. 
  • Apply and individualize the current treatment guidelines for type 2 diabetes mellitus using patient vignettes.

Like your favorites to provide us feedback!

Target Audience

This activity was planned to meet the educational needs of physicians, pharmacists, nurse practitioners, and physician assistants caring for patients with type 2 diabetes mellitus.

Format

This online activity consists of slide presentations, active learning, an assessment, and evaluation. View the system requirements. 

Disclosures

In accordance with ACCME and ACPE Standards for Commercial Support, ASHP policy requires that all faculty, planners, reviewers, staff, and others in a position to control the content of this presentation disclose their financial relationships. 

In this activity, only the individual/s below has disclosed a relevant financial relationship.  No other persons associated with this presentation have disclosed any relevant financial relationships.

Curtis L. Triplitt

  • AstraZeneca; Boehringer Ingelheim; Eli Lilly; Janssen - Speakers Bureau
  • Merck - Consultant

Eric L. Johnson

  • Medtronic - Speakers Bureau
  • Novo Nordisk - Advisory Board, Speakers Bureau
  • Sanofi - Advisory Board

Claim CE Within 60 Days

Participants should claim CE credit for this home-study activity only if they have not claimed credit for the live activity.

To receive CE credit, complete the steps below within 60 days of completing the activity.

  1. View entire presentation and answer all polling questions.
  2. Click "Complete Activity" on the last slide to complete the assessment and evaluation.
  3. Verify credits were successfully transferred to CPE Monitor before the ACPE 60-day deadline by checking your NABP eProfile account. 

After the 60-day deadline, ASHP will no longer be able to report credit(s).

CPE Information

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

ACPE #: 0204-0000-18-433-H01-P
Release Date: March 1, 2019
Expiration Date: May 31, 2020
Activity Type: Application-based
CE Credits: 1.5 hours
Activity Fee: Free of charge

CME Information

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Society of Health-System Pharmacists designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.